Description of the Human Atrial Action Potential Derived From a Single, Congruent Data Source: Novel Computational Models for Integrated Experimental-Numerical Study of Atrial Arrhythmia Mechanisms by Colman, MA et al.
fphys-09-01211 September 7, 2018 Time: 15:8 # 1
ORIGINAL RESEARCH
published: 07 September 2018
doi: 10.3389/fphys.2018.01211
Edited by:
Oleg Aslanidi,
King’s College London,
United Kingdom
Reviewed by:
Yael Yaniv,
Technion – Israel Institute
of Technology, Israel
Eleonora Grandi,
University of California, Davis,
United States
*Correspondence:
Michael A. Colman
m.a.colman@leeds.ac.uk
Specialty section:
This article was submitted to
Computational Physiology
and Medicine,
a section of the journal
Frontiers in Physiology
Received: 03 May 2018
Accepted: 13 August 2018
Published: 07 September 2018
Citation:
Colman MA, Saxena P, Kettlewell S
and Workman AJ (2018) Description
of the Human Atrial Action Potential
Derived From a Single, Congruent
Data Source: Novel Computational
Models for Integrated
Experimental-Numerical Study
of Atrial Arrhythmia Mechanisms.
Front. Physiol. 9:1211.
doi: 10.3389/fphys.2018.01211
Description of the Human Atrial
Action Potential Derived From a
Single, Congruent Data Source:
Novel Computational Models for
Integrated Experimental-Numerical
Study of Atrial Arrhythmia
Mechanisms
Michael A. Colman1* , Priyanka Saxena2, Sarah Kettlewell2 and Antony J. Workman2
1 Leeds Computational Physiology Lab, School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom,
2 Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow,
Glasgow, United Kingdom
Introduction: The development of improved diagnosis, management, and treatment
strategies for human atrial fibrillation (AF) is a significant and important challenge in
order to improve quality of life for millions and reduce the substantial social-economic
costs of the condition. As a complex condition demonstrating high variability and
relation to other cardiac conditions, the study of AF requires approaches from multiple
disciplines including single-cell experimental electrophysiology and computational
modeling. Models of human atrial cells are less well parameterized than those of the
human ventricle or other mammal species, largely due to the inherent challenges in
patch clamping human atrial cells. Such challenges include, frequently, unphysiologically
depolarized resting potentials and thus injection of a compensatory hyperpolarizing
current, as well as detecting certain ion currents which may be disrupted by the cell
isolation process. The aim of this study was to develop a laboratory specific model of
human atrial electrophysiology which reproduces exactly the conditions of isolated-cell
experiments, including testing of multiple experimental interventions.
Methods: Formulations for the primary ion currents characterized by isolated-cell
experiments in the Workman laboratory were fit directly to voltage-clamp data; the fast
sodium-current was parameterized based on experiments relating resting membrane
potential to maximal action potential upstroke velocity; compensatory hyperpolarizing
current was included as a constant applied current. These formulations were integrated
with three independent human atrial cell models to provide a family of novel models.
Extrapolated intact-cell models were developed through removal of the hyperpolarizing
current and introduction of terminal repolarization potassium currents.
Results: The isolated-cell models quantitatively reproduced experimentally measured
properties of excitation in both control and pharmacological and dynamic-clamp
interventions. Comparison of isolated and intact-cell models highlighted the importance
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of reproducing this cellular environment when comparing experimental and simulation
data.
Conclusion: We have developed a laboratory specific model of the human atrial cell
which directly reproduces the experimental isolated-cell conditions and captures human
atrial excitation properties. The model may be particularly useful for directly relating
model to experiment, and offers a complementary tool to the available set of human
atrial cell models with specific advantages resulting from the congruent input data
source.
Keywords: atrial fibrillation, human atrial model, ion channel currents, computational model, action potential
INTRODUCTION
The incidence of atrial fibrillation (AF) is growing in epidemic
proportions (Ceornodolea et al., 2017): the current prevalence of
2% in western countries is more than double that of over a decade
ago (Zoni-Berisso et al., 2014) and its association with aging has
led to projections of significant increase in the next few decades
(Krijthe et al., 2013). AF increases the risk of death, mainly as a
consequence of the associated four to fivefold increased risk of
stroke, and results in significant costs to worldwide healthcare
systems (Casajuana et al., 2018). Presently available treatment
strategies are far from ideal: pharmacological intervention has
sub-optimal efficacy in patients, and also risks adverse effects
in certain patient groups; catheter ablation is invasive and may
require repeated procedures (Kirchhof et al., 2016; Kirchhof
and Calkins, 2017). The development of improved diagnosis,
management, and treatment strategies for AF is therefore a
significant and important challenge in order to improve quality of
life for millions and reduce the substantial socio-economic costs
of the condition.
The mechanisms driving the sustained rapid and irregular
excitation during AF are controlled partly at the cellular level by
the non-linear interactions of multiple ion currents underlying
the action potential (AP), and thus these currents also influence
the impact of pharmacological or surgical interventions. It is
therefore vital to fully characterize the dynamics of these ion
currents. Compounding the problem, expression and kinetics of
these currents can be highly variable (e.g., Lawson et al., 2018),
are modified by autonomic control (e.g., Chen and Tan, 2007;
Workman, 2010), and can remodel in the long-term presence of
AF (e.g., Workman et al., 2001); excitation dynamics at the tissue-
scale may also be highly non-linear and unpredictable from
single-cell studies alone (e.g., Colman et al., 2017b). It is therefore
a significant challenge to comprehensively quantify the role of ion
currents (and their variation, modulation, and remodeling) in the
mechanisms of atrial arrhythmia.
Computational modeling has proved to be an increasingly
valuable tool to assess and dissect the impact of ion channel
function and anatomical structure on normal and arrhythmic
human atrial electrical dynamics (Colman et al., 2014; Trayanova,
2014; Heijman et al., 2016): the number of simulation studies
has significantly increased over the last decade and there are
currently multiple contemporary models of the human atrial AP
and calcium handling available (e.g., Courtemanche et al., 1998;
Nygren et al., 1998; Maleckar et al., 2009; Grandi et al., 2011;
Koivumäki et al., 2011; Colman et al., 2013). Despite the successes
of simulation studies, human atrial cell models are in general less
well parameterized than ventricular cell models, and they still rely
on model components formulated on data from different sources,
cell-types, and even species (Wilhelms et al., 2013); integration
of components from different sources is non-trivial and often
requires enforced parameter modification. Even integration of
human atrial specific data from multiple sources is non-trivial
due to the challenges of obtaining reliable data (Nattel, 2006),
including substantial inter-patient, inter-isolate, and inter-cell
variability. Also, subtle inter-laboratory differences, as well as
variations in operative techniques and concomitant therapies,
may influence the outcome of experiments in major ways, making
multi-center studies challenging and providing uncertainty in
the combination of mathematical descriptions based on data
from multiple laboratories. Moreover, the recent trend has been
toward introducing more components and additional complexity
and sophistication; whereas this has proved useful in teasing
apart ionic contributions to health and disease, it nevertheless
provides more potential sources of error and reliance on a larger
set of unknowns and/or ad hoc parameters. There is therefore
motivation to derive a computational model based on human
atrial data with the fewest non-specific additional components,
and also specifically on data from a single source (i.e., consistent
cell source and experimental environment and protocols).
There are numerous further challenges in obtaining reliable
experimental data for developing a human atrial-specific cell
model. These include inherent difficulties in acquiring human
atrial tissues and acutely isolating cardiomyocytes from them,
since they cannot be arterially perfused with enzymes. The
“chunk technique” (Yue et al., 1996), in which small chunks of
tissue are superfused with enzymes, is used to overcome this
problem, but also has recognized limitations including potential
disruption of ion currents such as the delayed rectifier potassium
currents IKr and/or IKs (Yue et al., 1996; Workman et al.,
2006), relatively low cell yield, and often an unphysiologically
depolarized resting membrane potential (RMP; Escande et al.,
1987; Bénardeau et al., 1996; Van Wagoner et al., 1999; Dobrev
et al., 2001; Workman et al., 2006) to the extent that the fast
sodium current (INa) may be unavailable. RMP depolarization
can be mitigated in various ways, none without limitations,
including injecting a constant background (hyperpolarizing)
current during recording, as used routinely in the Workman
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laboratory (WL). This method permits full repolarization of the
AP and thus INa availability, but must be used sparingly and with
caution; see Workman et al. (2006) for details. Computational
models of atrial cells therefore do not necessarily directly translate
to the isolated-cell experiments on which they are validated
and which they themselves inform. There is therefore also
motivation to develop a cell model which reproduces specifically
the conditions of isolated whole-cell-patch current- and voltage-
clamp experiments, for full congruence between experimental
and simulation studies.
The aim of this study was to develop a human atrial isolated-
and intact-cell model based primarily on specific human atrial
cellular data from the WL, with motivation to introduce the
fewest additional components from other sources. The model
was tested for its ability to reproduce experimental observations
for AP properties and their modulation by pharmacological
and dynamic-clamp interventions. Furthermore, the descriptions
of the set of the primary currents were integrated with
contemporary human atrial cell models to provide a novel set
of modified cell models, and used to assess the importance of
the isolated-cell environment in AP morphology and response
to various interventions. The resulting models therefore form
a complementary tool to the available set of human atrial cell
models, providing both a minimal approach with the emphasis
on congruent input data which allows direct interaction between
simulation and experiment, and a family of cell models suitable
for mechanistic evaluation of atrial arrhythmias.
MATERIALS AND METHODS
In this study, novel formulations of the primary ion currents
underlying human atrial electrophysiology and characterized in
the WL were developed (sections “Isolated-Cell Experiments”
and “Ion Current Formulations”). The formulations were
integrated with multiple contemporary human atrial cell
models, including both isolated- and intact-cell variants (section
“Computational models”). The Courtemanche et al. (1998)
model (hAM_CRN), Nygren et al. (1998) model (Nygren-Giles,
hAM_NG), and Grandi et al. (2011) [Grandi-Bers, hAM_GB –
specifically, the implementation of Chang et al. (2014)] were
selected as these represent the baseline cell models underlying
the primary distinct lines of human atrial cell model development
[not including spatial cell models such as Koivumäki et al. (2011)
and Voigt et al. (2014)]. Full model equations and parameters
are provided in the Supplementary Material and model code in
C/C++ is available from the GitHub repository1.
Isolated-Cell Experiments
Isolated-cell experiments described pertain to both previously
published and unpublished data characterizing the primary
human atrial ion currents: fast sodium current (INa); transient-
outward current (Ito); L-type calcium current (ICaL); ultra-
rapid, or sustained, potassium current (IKur/sus); and the time-
independent potassium current (IK1); as well as additional
1https://github.com/michaelcolman/hAM_WL
intracellular calcium concentration ([Ca2+]i) data associated
with the calcium transient (CaT).
A summary of the experimental conditions associated with
each study is provided in Table 1 and described briefly. Right
atrial tissues were obtained from consenting patients undergoing
cardiac surgery between 1999 and 2018. All patients were in
sinus rhythm unless otherwise stated, and were taking a variety
of drug treatments as detailed in the following publications. The
whole-cell patch clamp technique and fluorescence microscopy
were used to record ion currents, APs, effective refractory period
(ERP), and intracellular Ca2+ concentration ([Ca2+]i), at 35–
37◦C, in the absence and presence of a variety of drugs, from atrial
myocytes enzymatically isolated from these tissues. Procedures
were approved by the West of Scotland Research Ethics Service
(REC 99MC002 and REC 17/WS/0134). The chunk method of
cell isolation used is detailed in Workman et al. (2001), and all the
experimental conditions, patch-clamp configurations, recording
protocols, and solutions used, are included in Workman et al.
(2006, 2012) and Marshall et al. (2012). Specific data on individual
ion currents, APs, or ERP are derived from the following WL
published sources: APs, current magnitudes, and ERP: Workman
et al. (2001, 2006) (referred to in short as WL_2001; WL_2006);
IK1: Marshall et al. (2012) (referred to as WL_2012_IK1); Ito and
Isus: Workman et al. (2012) (WL_2012_ITO); ICaL: Pau et al.
(2007) (WL_2007_ICAL). WL_2006 was considered the most
representative collective data and was therefore used to set the
relative magnitudes of the currents in the computational models.
INa data were derived using recent unpublished data obtained
from human atrial isolated myocytes (by Priyanka Saxena in the
WL) on the relationship between current-clamped RMP and AP
phase 0 maximum upstroke velocity (dV/dtmax) as a surrogate
for the voltage-dependence of INa (which cannot be directly
measured accurately) in these cells. [Ca2+]i data (unpublished)
were recently recorded in human atrial isolated myocytes (by
Sarah Kettlewell in the WL), using identical techniques to those
employed earlier in rabbit atrial myocytes in this laboratory
(Kettlewell et al., 2013).
Only specific data on the ion currents were used to derive the
mathematical model; AP, excitation, and intervention data were
used for validation and comparison only, and not to further train
the model.
Ion Current Formulations
Workman-Laboratory Characterized Currents: IK1
and Ihyp
The current–voltage (IV) relationship for the time-independent
current, IK1, was considered from both WL_2012_IK1
[Figure 1A(i)] and WL_2006 [Figure 1A(ii)], where the
former data correspond to Ba2+-sensitive specific IK1, and the
latter may more accurately refer to a general voltage-dependent,
time-independent current. Integrating the formulation of the
current from WL_2012_IK1 with the background currents of
the selected baseline human atrial cell models led to maintained
RMP of below −70 mV in all models. The apparent reversal in
the WL_2006 data and formulation of approximately −40 mV
[Figure 1A(ii)] was necessary to result in the unphysiologically
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depolarized RMP of isolated-cells. These formulations were
therefore suitable for use in the intact- and isolated-cell models,
respectively, and are thus referred as IK1intact (WL_2012_IK1
data) and IK1isolated (WL_2006 data) for clarity. The IV
relationship associated with IK1 in the primary, independent
human atrial cell models is shown for reference in the IK1intact
panel [Figure 1A(i)].
The relationship between RMP and the magnitude of the
hyperpolarizing current (Ihyp) for isolated-cell models with three
different magnitudes of IK1 (0.5, 1, and 2 × maximum of
−4 pA/pF at −120 mV; Workman et al., 2006) demonstrates
hyperpolarizing currents of 0.4–1.4 pA/pF were necessary for
maintaining a RMP of ∼−80 mV [Figure 1A(iii)], congruent
with the magnitude of current used and reported in the isolated-
cell experiments. An Ihyp of 0.63 pA/pF was used with the
default scaling of IK1 for the baseline cell model, giving a
RMP of −82 mV when integrated with the hAM_CRN calcium
handling system and background currents. This value of Ihyp
closely matched that reported in experiments, e.g., 0.62 pA/pF
(Workman et al., 2006). This value also maintained a RMP
of ∼−80 mV when combined with the background currents
and calcium handling system in the hAM_NG (−75 mV) and
hAM_GB (−80 mV) models. To ensure consistent conditions
between models, this value of Ihyp was maintained rather than
imposing identical RMP.
Workman-Laboratory Characterized Currents: Ito and
Isus
The formulations for the transient-outward (Ito) and
sustained/ultra-rapid potassium (Isus/IKur) currents were
derived from the voltage-clamp (100 ms pulse in 10 mV
steps from −50 to 70 mV) data from WL_2012_ITO.
TABLE 1 | Control experimental conditions used for human atrial cell electrophysiological recordings, including intra- and extra-cellular ionic constituents,
[Ca2+]i-buffering and temperature (all closely matching and within mammalian physiological ranges), recording configurations and measurements taken.
Study WL_2001 (Workman
et al., 2001)
WL_2006 (Workman et al.,
2006)
WL_2007 _ICAL (Pau
et al., 2007)
WL_2012 _IK1
(Marshall et al., 2012)
WL_2012 _ITO
(Workman et al.,
2012)
Intracellular solution
constituents (mM,
pH)
L-aspartate (110), KCl
(20), MgCl2 (1.0), EGTA
(0.15), Na2ATP (4.0),
Na2GTP (0.4), HEPES
(5.0), pH 7.3
For ruptured-patch:
K-aspartate (110), KCl (20),
MgCl2 (1.0), EGTA (0.15),
Na2ATP (4.0), Na2GTP (0.4),
HEPES (5.0), nystatin (0.18);
pH 7.3 For perforated-patch:
KCl (30), HEPES (5.0), MgCl2
(1.0), K methane-sulfonic acid
(100), NaCl (5.0); pH 7.3
KCl (30), HEPES (5),
MgCl2 (1), K
methane-sulfonic acid
(100), NaCl (5), nystatin
(0.18); pH 7.3
K-aspartate (110), KCl
(20), MgCl2 (1.0), EGTA
(0.15), Na2ATP (4.0),
Na2GTP (0.4), HEPES
(5.0); pH 7.3
K-aspartate (130), KCl
(15), NaCl (10), MgCl2
(1), HEPES (10), EGTA
(0.1); pH 7.3
Extracellular
solution
constituents (mM,
pH)
NaCl (130), KCl (4.0),
CaCl2 (2.0), MgCl2
(1.0), glucose (10),
HEPES (10), pH 7.4
NaCl (130), KCl (4.0), CaCl2
(2.0), MgCl2 (1.0), glucose (10),
HEPES (10); pH 7.4
NaCl (130), KCl (4.0),
CaCl2 (2.0), MgCl2
(1.0), glucose (10),
HEPES (10), pH 7.4
NaCl (130), KCl (4.0),
MgCl2 (1.0), CaCl2
(2.0), glucose (10),
HEPES (10); pH 7.4
NaCl (140), KCl (4.0),
CaCl2 (1.8), MgCl2
(1.0), glucose (11),
HEPES (10); pH 7.4
LLJP correction Yes Yes Yes Yes Yes
Recording
temperature
35–37◦C 35–37◦C 35–37◦C 35–37◦C 35–37◦C
[Ca2+]i-buffering Minimal (0.15 mM
EGTA)
Minimal (0.15 mM EGTA for
ruptured-patch; zero EGTA for
perforated-patch)
Minimal (zero EGTA as
perforated-patch)
Minimal (0.15 mM
EGTA)
Minimal (0.10 mM
EGTA)
Cell isolation
enzyme
Collagenase (Type 1,
Worthington, 400 U/ml)
Collagenase (Type 1,
Worthington, 400 U/ml)
Collagenase (Type 1,
Worthington, 400 U/ml)
Collagenase (Type 1,
Worthington, 400 U/ml)
Collagenase (Type 1,
Worthington, 400 U/ml)
Patch configuration Ruptured patch Ruptured patch
Nystatin-perforated patch
Nystatin-perforated
patch
Ruptured patch Ruptured patch
Patch-clamp
amplifier
Axopatch-1D (Axon) Axopatch-1D (Axon) Axopatch-1D (Axon) Axopatch-1D (Axon) AxoClamp 2B (Axon)
Recording
configuration
Current-clamp
Voltage-clamp
Current-clamp Voltage-clamp Current-clamp
Voltage-clamp
Voltage-clamp Current-clamp
Voltage-clamp
Dynamic-clamp
Measurements APs, ERP, ICaL, ITO, IK1,
IKSUS
APs, ERP, ICaL, ITO, IK1, IKSUS APs, ERP, ICaL ITO, IK1, IKSUS APs, ITO
LLJP, liquid-liquid junction potential; AP, action potential; ERP, cellular effective refractory period; ICaL, L-type Ca2+ current; Ito, transient outward K+ current; IK1, inward
rectifier K+ current; Isus, sustained outward K+ current (mainly IKur).
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FIGURE 1 | Fitting the Workman-lab K+ characterized currents. (A) Fitting IK1 and the hyperpolarizing current (Ihyp). (i) IK1 measured in the WL_2012_IK1 study
(Marshall et al., 2012), considered “intact” (black circles) and simulation fits from the new formulations (purple) and the three human atrial models [orange –
CRN(Courtemanche et al., 1998); green – NG (Nygren et al., 1998); blue – GB (Grandi et al., 2011)]. (ii) IK1 measured in the WL_2006 (Workman et al., 2006) study,
considered “isolated” (gray) and model fit (purple). The form of the “intact” current is shown for reference, with arrows indicating the difference in reversal between
the intact and isolated variants. (iii) Relationship between resting membrane Potential (RMP) and Ihyp at three different amplitudes of IK1isolated (baseline – closed
circles, purple; IK1 × 2 – closed squares, orange; IK1 × 0.5 – closed triangles, blue). (B,i–iii) Fitting of the gating variable parameters for Ito and Isus to the
voltage-clamp data of WL_2012_ITO (Workman et al., 2012) (iv) and resulting simulated current traces (v) and IV relationship (inset). Open, light blue symbols refer
to values calculated from fitting to individual current traces. Open, dark blue symbols refer to mean current data from WL_2012_ITO (Workman et al., 2012). The
formulation from Maleckar et al. (2009) is shown for reference in panel iii. In the inset for panel iv, Ito is shown in purple, Isus in light blue, and corrected Isus in dark
blue. Figure created using data from: Workman et al. (2006, 2012) and Marshall et al. (2012).
The baseline formulation for Ito was the same as that
presented in the original study. The baseline formulation
for Isus was taken from Maleckar et al. (2009), derived on
human atrial cell data. First, the maximum conductances
(gto, gsus) were set to give the appropriate magnitude
current at the +70 mV clamp step (where each channel
is considered to be fully activated). Then, each current
was fit to individual, representative experimental current
traces [using a least-squares optimization algorithm
implemented in Python (Python Software Foundation2)]
2https://www.python.org/
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FIGURE 2 | Parameterizing INa through resting membrane potential (RMP) vs dV/dtmax. (A) AP upstroke associated with multiple RMP conditions in experiment (i)
and simulation (ii). (B) Relationship between dV/dtmax and RMP in experiment (open circles, blue; n = 10 cells, 4 patients), parameterized INa model (solid-purple
line, triangles), and original INa model (Luo and Rudy, 1991) (dotted orange line, squares). Experimental data: unpublished, Priyanka Saxena.
to provide steady-state and time constant values for the
activation and inactivation gates at each voltage step,
optimized for the numerical solution of the governing
equations. The voltage dependence functions describing
the steady-states and time constants were then fit to a
combination of these values (from a single experiment)
and the mean measured values from all experiments
[Figures 1B(i–iii)], producing current traces from a combined
Ito–Isus voltage-clamp which match well to experiment
[Figures 1B(iv,v)].
The conductance parameters were adjusted to reflect the
data described in WL_2006 (Workman et al., 2006): setting
gto, the maximal conductance of Ito, to 0.103 nS/pF gave a
peak current of 12.5 pA/pF at +60 mV; the proportionally
set maximal conductance of 0.040 nS/pF for Isus gave a peak
current of 5.17 pA/pF, below the value of 10.6 ± 0.8 pA/F
described in the data. Therefore, a corrected Isus maximal
conductance of 0.068 µS/pF was set to reflect these data
[Figure 1B(v-inset)].
Parameterizing the Fast Sodium Current, INa
To overcome the challenge of characterizing the voltage-
dependence of INa, previously unpublished human atrial
experimental data (from Priyanka Saxena in the WL) relating
the RMP to dV/dtmax were used to modify the parameters
of the formulation for INa originally presented by Luo
and Rudy, 1991 and used as the baseline in multiple
contemporary AP models including those of the human
atria (Courtemanche et al., 1998; Grandi et al., 2011). These
experimental data were obtained using the same patch-
clamp amplifier (chosen for its accurate voltage-following) and
recording solutions (including accurate liquid–liquid junction
potential correction) as in WL_2012_ITO (Workman et al.,
2012) and dV/dtmax measured using WinWCP software (John
Dempster). Re-parameterization of this formulation to the data
resulted in good agreement between experiment and simulation
in the AP upstroke [Figures 2A(i,ii)] and dependence of
dV/dtmax on RMP (Figure 2B), which was significantly different
to that observed with the original, ventricular formulation
(Figure 2B).
Workman-Laboratory Characterized Currents: ICaL
The L-type calcium current, ICaL, presents a larger challenge
to model than the previous currents described due to its
tight coupling with the intracellular calcium handling
system: the current is responsible for initiating intracellular
calcium-induced-calcium-release (CICR) and also has
implicit calcium-induced inactivation gating. Detailed
electrophysiological data for the human-atrial calcium handling
system, and calcium-induced inactivation of ICaL, are limited
(with notable exceptions, e.g., Voigt et al., 2014), and there
is limited CaT data available from the WL. Therefore, the
formulation for ICaL was considered in conjunction with
the computational models of the calcium-handling system
implemented. Each of the three selected models (hAM_CRN;
hAM_NG; hAM_GB; see sections “Materials and Methods”
and “Computational Models”) contain different descriptions
of CICR and calcium-induced inactivation of ICaL, and
model stability and homeostasis can be sensitive to these
components.
In the first instance, the native formulations of ICaL in
each of these models was retained, with only the voltage
dependence being modified to fit the experimental IV
relationship presented in WL_2007_ICAL and WL_2001
(Figure 3), and the maximum conductance set to give a
peak current of −5 pA/pF, as reported in WL_2006. Models
implementing these formulations of ICaL are referred to
as the modified-WL models (see section “Computational
Models”).
In the second instance, a new formulation for ICaL was
developed which more closely reproduces the time-course
of the experimentally measured current [Figure 3A(i)] and
was suitable for implementation with both the hAM_CRN
and hAM_GB calcium handling systems. The hAM_NG
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FIGURE 3 | Fitting the L-type calcium current. (A) Current traces for experimental (Pau et al., 2007) (i) and simulated (ii–v) ICaL under voltage clamp conditions for
the modified WL formulations (ii–iv) and novel WL formulation (v), scaled over 500 ms (left) and 50 ms (right). (B,i–iii) Comparison of the IV relationship between the
modified (purple) and native (light blue) currents against normalized experimental data [dark blue – WL data: circles – WL_2001 (Workman et al., 2001); triangles –
WL_2007_ICaL (Pau et al., 2007); orange – data from other labs: Van Wagoner et al. (1999) – squares; Christ et al. (2004) – triangles]. All experimental data are
normalized; native simulation data are normalized to the modified peak current, to illustrate the difference in current magnitude between native and modified models.
(B,iv) The IV relationship for the novel, WL formulation. Figure created using data from: Van Wagoner et al. (1999), Workman et al. (2001), Christ et al. (2004) and
Pau et al. (2007).
calcium handling system was not used for this purpose due
to its sensitivity to changes in ICaL and unphysiological
CaT magnitude and morphology. The novel formulation
implemented the dynamic conductance of ICaL of hAM_GB,
and was designed to work with both the differing calcium-
induced inactivation formulations and CaT time-course
associated with each model. This was achieved through first
fitting the current formulations (comprising voltage-induced
activation and inactivation only) to the voltage clamp data
of WL_2007_ICAL, using the same approach as Ito/Isus (see
section “Workman-Laboratory Characterized Currents: Ito
and Isus”). Then, the equations were modified to account for
calcium-induced inactivation, with priority on maintaining
uniformity in behavior between implementation with each
calcium-handling system [Figures 3A(v),B(iv)]. This was
the formulation used for the full WL models (see section
“Computational Models”).
Computational Models
A family of human atrial cell models is presented which
incorporate the formulations for the ion currents described
above. First, a minimal approach was used to develop novel
models of the isolated-cell human atrial AP: the novel
formulations for INa, Ito, Isus, ICaL, IK1isolated, and Ihyp were
integrated with the intracellular calcium handling models
associated with hAM_CRN and hAM_GB (see section
“Workman-Laboratory Characterized Currents: ICaL”); the
additional membrane current components necessary for
intracellular homeostasis (and unquestionably present in
human atrial myocytes; INaCa, INaK, ICaP, ICab, INab) were
introduced using the formulations associated with each calcium
handling system. Implementation with the hAM_GB model also
retained additional background currents (IKb, IClb) and other
components (IClCa). These models, fit as completely as possible
to the experimental observations of the WL, are referred to as
hAM_WLCRNisolated and hAM_WLGBisolated. Intact-cell variants
of these models (hAM_WLCRNintact, hAM_WLGBintact) were
derived by removal of Ihyp, replacing IK1isolated with IK1intact, and
then minimally introducing IKr and IKs as necessary (see section
“Intact-Cell Model”) to maintain physiological human atrial AP
duration.
Second, the selected human atrial cell models were modified
to reproduce the isolated-cell experimental environments and
incorporate the novel ion current formulations: isolated-
cell modifications (hAM_Xisolated) were implemented by the
introduction of the new formulation for IK1isolated and Ihyp,
and setting the conductances of IKr and IKs to zero. Modified
cell models (hAM_XmWL), for both isolated and intact-cells,
were implemented by replacing the native formulations of INa,
Ito, Isus, and IK1 with the novel formulations presented, and
the formulation of ICaL with the modified variants associated
with each calcium handling system (see section “Workman-
Laboratory Characterized Currents: ICaL”). Thus, the present
study considers the following models: the three hAM_CRN,
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hAM_NG and hAM_GB as originally presented; the two novel
presented WL based models (hAM_WLCRN/GB); and the three
modified WL models (hAM_CRN/NG/GBmWL); all with isolated
an intact variants.
Action potentials were initiated using a train of applied stimuli
of magnitude −13.5 pA/pF for 3 ms. All models were paced to
stable-state before results were obtained, with a minimum of 200 s
pre-pacing stimuli.
RESULTS
Isolated-Cell Model Characteristics and
Validation
The time-courses of the AP for the five novel model variants all
exhibit very similar morphologies [Figure 4A(i)]; the differences
in morphology observed are primarily a result of either the
different ICaL formulations (see section “Workman-Laboratory
Characterized Currents: ICaL”), calcium-induced inactivation
dependent on the CaT morphology, or the interaction with
calcium-handling currents such as INCX. Comparison between
the model and experimental APs shows good agreement in
duration and morphology with the typical WL AP, exhibiting the
low and triangular-like plateau morphology [Figures 4A(ii,iii)].
APD restitution also matches well with experimental data from
WL_2001 [Figure 4B(i)], which is in general shorter than the
data presented by other groups (Franz et al., 1997; Bosch
et al., 1999). The different model variants exhibited different
rate dependence of the MDP, with all but the hAM_NGmWL
model closely matching the experimental data [Figure 4B(ii)].
Comparison of APD90 and dv/dtmax between model and
experiment (WL_2001 and WL_2006) at 75 BPM showed all
of the models exhibit properties close to the experimental
value, with variation in dv/dtmax between the models being
larger than that for the APD90. This is a result of the
different RMPs maintained by the consistent hyperpolarizing
current.
The intracellular CaT exhibited large differences between
model variants dependent on the underlying calcium handling
system [Figure 4C(i)]: the hAM_NGmWL model retained the very
rapid and large amplitude spike associated with the NG model;
the CRN and GB variants (WL and modified) exhibited more
prolonged CaTs within the physiologically expected amplitude
range (∼0.4–0.5 µM). The CRN model variants most closely
reproduced the time-course of the CaT [Figure 4C(ii)]; the
GB model variants exhibited a similar morphology but with a
delayed onset. The GB model variants reproduced the diastolic
and peak values most closely compared to mean experimental
data [Figure 4C(iii)].
Interventions
The five novel model variants (novel WL with CRN/GB calcium
handling; CRN/NG/GB WL-modified models) were compared
against experimental data from the WL under the application
of various pharmacological or dynamic-clamp intervention. The
role of Ito was assessed through comparison to the dynamic-
clamp data of WL_2012_ITO [Figure 5A(i)]: the magnitude of Ito
was scaled by a factor of zero to two, reproducing the subtraction
and addition of up to the full magnitude of current in experiment.
All novel model variants reproduced the main features of the
intervention, most pertinently the negative correlation between
Ito magnitude and terminal repolarization duration (Figure 5A).
However, the magnitude of the impact of Ito modulation was
different among the different model variants. As all models
contain the same formulation for Ito, these differences were due
to either (a) the impact of AP morphology and/or (b) the differing
formulations for ICaL, calcium handling system, and background
currents.
The role of ICaL was assessed through the application of
nifedipine (channel blocker, WL_2001 data, modeled by 30–90%
current block) and 5HT (channel enhancer, WL_2007_ICaL data,
modeled by a three-fold increase in the current magnitude). The
impact of nifedipine was in general overestimated in the cell
models [Figure 5B – except for than the hAM_NGmWL variant;
Figure 5B(v)]; 5HT displayed more variable match between
model and experiment, with some models overestimating its
effects whereas others underestimated it (Figure 5E). After-
depolarizations or non-repolarizing APs were observed in the
hAM_WLCRN and hAM_NGmWL model variants under a large
increase in ICaL. Qualitatively, all models reproduced the
features of these two interventions: nifedipine reducing the AP
dome/plateau phase and accelerating terminal repolarization,
whereas 5HT enhanced this plateau phase and extended terminal
repolarization.
The impact of 4-AP (50% block of Ito and Isus) was well
reproduced by all model variants, displaying an elevation of the
AP plateau and extension of terminal repolarization (Figure 4C).
Similarly, the match between simulation and experiment for
the application of 4-AP combined with nifedipine was strong,
wherein all models reproduce the triangular morphology,
prolonged phase-1 repolarization, and accelerated terminal
repolarization (Figure 5D). The extent of APD shortening
differed between the model variants, although all displayed some
but not extensive shortening, as observed in experiment.
Intact-Cell Model
The intact-cell models (for future tissue-scale simulations)
were derived through first exchanging the formulation of IK1
from the isolated to intact version (see Figure 1 and section
“Workman-Laboratory Characterized Currents: IK1 and Ihyp”),
and subsequent removal of the hyperpolarizing current. The
RMP maintained in the cell model variants was ∼−74 mV,
similar to that of the native hAM_GB and hAM_NG models,
and less hyperpolarized than the isolated-cell model variants,
the hAM_CRN model, and WL experiments of ∼−80 mV.
For the case of the modified cell models (hAM_XmWL), IKr
and IKs were modeled as originally presented to preserve the
modified nature of the cell models; in case of the WL models
(hAM_WLCRN/GB), the currents were incrementally introduced
by scaling the maximum conductance of the associated model
current formulation to preserve the minimal approach: factor
of × 0–1.5 for the hAM_WLCRN model, and × 0–5.0 in the
hAM_WLGB model. With the conductances set to zero, neither
model maintained an APD expected of the intact healthy human
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FIGURE 4 | Simulated AP and CaT characteristics and validation. (A,i) Action potential (AP) traces associated with the five novel model variants, paced at 75 BPM;
(A,ii,iii) Comparison between the WL models (purple) and available experimental traces (blue; Workman et al., 2001, 2006, 2012; Pau et al., 2007 + Kettlewell
unpublished Ca2+ data), with the “typical” Workman laboratory trace emphasized. (B,i) APD90 restitution for the five models [colored lines – colors correspond to
those in A(i)] compared to experimental data from the Workman laboratory (blue circles; WL_2001; Workman et al., 2001) as well as from other groups for additional
context [orange triangles (Bosch et al., 1999); orange squares (Franz et al., 1997)]. (B,ii) Rate dependence of MDP in the five models and Workman laboratory data
(WL_2001). (B,iii) Comparison of APD90 and dv/dtmax at 75 BPM in the five models (colors; purple hatched bars corresponds to WLGB) and experiment (white:
WL_2001, open bars; WL_2006, hatched bars). (C) Intracellular calcium transients in the five model variants (colored lines) and single experimental trace from the
Workman laboratory (black; unpublished Sarah Kettlewell WL data), shown on absolute (i) and normalized (ii) scales. (iii) Comparison of the diastolic and peak
calcium in the five models with mean data (n = 24 cells, 5 patients) from the Workman laboratory Kettlewell experiments. Figure created using data from Franz et al.
(1997), Bosch et al. (1999), Workman et al. (2001, 2006, 2012) and Pau et al. (2007).
atria, exhibiting non-repolarizing APs [Figures 6A,B(i,ii)]. In
the hAM_WLCRN model, introducing the currents with the
conductance set to that presented originally was sufficient
to maintain and APD of <400 ms [Figures 6A,B(i)]; in
the hAM_WLGB model, larger conductances (relative to the
original study – note that the GB model has much smaller
IKr/IKs than the CRN model) were necessary to maintain APD
[Figures 6A,B(ii)]. All intact models with a duration of <400 ms
displayed either a spike-and-dome (hAM_CRNmWL) or low-
plateau/dome (all other variants) morphology [Figures 6A,B(i–
v)], and such durations could be achieved with relatively low
current magnitudes (i.e., an order of magnitude smaller than the
peak in Ito, Isus, and ICaL).
Role of the Hyperpolarizing Current
The importance of the hyperpolarizing current, and isolated-cell
conditions (i.e., IK1isolated with a reversal of ∼−40 mV;
insignificant IKr/IKs) was assessed by comparison of the intact
-and isolated-cell variants of the hAM_CRN, hAM_NG and
hAM_GB models (Figure 7). For all three models, the isolated-
cell variant exhibited a shorter APD90 with more rapid terminal
repolarization (Figure 7Aa). The dome associated with the
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FIGURE 5 | Dynamic clamp and pharmacological intervention. Comparison of experiment (i) and five model variants (ii–vi) under the application of: (A) Ito
dynamic-clamp, modeled as a zero–twofold scaling of the current; (B) nifedipine, modeled as a 30–90% block of ICaL (specifically 30, 50, 70, 80, and 90% block);
(C) 4-AP (Ito and Isus block); (D) 4-AP + nifedipine; (E) 5HT, 1.5 to three-fold scaling of ICaL. Ito data from WL_2012_ITO (Workman et al., 2012); Nif and 4-AP data
from WL_2001 (Workman et al., 2001); 5HT data from WL_2007_ICAL (Pau et al., 2007). Figure created using data from: Workman et al. (2001, 2012) and Pau et al.
(2007).
hAM_CRN model was flattened, and the long tail associated
with the hAM_GB model was significantly reduced. The
CaT was significantly reduced in isolated-cells in both the
hAM_CRN and hAM_GB models, whereas the hAM_NG model,
in general, showed the most similarity between isolated and
intact [Figure 7A(ii)]. APD restitution was affected similarly,
with APD90 being significantly shortened at all except the fastest
pacing rates (shortest cycle lengths), where convergence between
isolated and intact-cell models in the hAM_CRN and hAM_NG
model was observed (Figure 7Ac).
Analysis of the response of the AP to various interventions
revealed some significant differences between isolated- and
intact-cell model variants, pertaining both to proportional
and behavioral differences. Selected examples illustrate the
most significant differences observed (Figure 7B): the dynamic
clamp Ito intervention in the hAM_CRNisolated model matched
well to the experimental data (Figure 5A), wherein terminal
repolarization duration negatively correlated with Ito magnitude,
whereas in hAM_CRNintact, a positive correlation was observed,
wherein initial elevation of the plateau under current block
led to more rapid and thus shorter terminal repolarization
[Figure 7B(i)]. The response to 4-AP in the hAM_CRN model
variants demonstrated the same feature: APD90 was prolonged
in the isolated-cell model but shortened in the intact-cell model
[Figure 7B(ii)]. In the hAM_GB model variants, modulation
of ICaL exhibited the largest differences between isolated- and
intact-cell models: the application of nifedipine (i.e., ICaL current
block) exhibited differences in the graded response to gradually
increasing current block [Figure 7B(iii)]; the application of
5HT (i.e., ICaL current enhancement) resulted in early-after-
depolarizations (EADs) in the intact-cell model which were not
observed in the isolated-cell model [Figure 7B(iv)].
Comparison Between Models
The IV relationship and current traces under voltage clamp for
the novel formulations and inherited cell models demonstrate the
variability between the different cell models (Figure 8). The IV
curves for Ito in the CRN, NG, and GB models all demonstrate a
takeoff potential of−30 to−20 mV, whereas the WL formulation
exhibits a takeoff potential of−10 to 0 mV, and a smaller current
magnitude [Figure 8A(i)]. The GB model (i.e., Maleckar et al.,
2009 formulation) had the slowest decay time, with all other
models being more similar [Figure 8B(i)]. Isus is largest in the WL
model, but exhibits similar voltage dependence to the NG and
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FIGURE 6 | Intact-cell models. (A) AP and (B) IKr and IKs current traces for the five model variants (i–v) under isolated and intact conditions. For panels (i,ii), colors
correspond to the isolated-cell model (purple), intact-cell model without introduction of IKr and IKs (red), and introduction of a small amount of each current (orange,
green, blue). The scale factors for the WLCRN and WLGB models are indicated in their respective panels. In iii–v, just the isolated (purple) and intact (blue) variants are
shown. In B, solid lines refer to IKr and dotted lines to IKs.
GB models [Figure 8A(ii)]. The model ICaL formulations show
similar voltage dependence and magnitude for the WL, CRN,
and NG models, with the GB model being both larger and with
a negative shift in its voltage dependence [Figure 8A(iii)]. The
inter-model differences in the time-course of ICaL traces during
voltage clamp are larger, with the WL model showing the fastest
decay.
The influence of the novel current formulations on atrial AP
morphology is illustrated through comparisons of the native
(hAM_X), modified (hAM_XmWL), and novel (hAM_WLX)
cell models (Figure 9A). In both isolated and intact-cell
environments, the AP morphology and time-course of the
various currents exhibits significant differences between the
native and novel versions, with the isolated modified versions
in general exhibiting closer features to the WL AP morphology
and duration. The time-courses for the novel Ito and Isus lie
somewhat intermediary to those associated with the hAM_CRN
and hAM_GB models.
The contribution of ion current balance (i.e., relative
magnitudes of the different currents) and kinetics to the
differences observed was assessed by comparing the native and
mWL models with variants in which the current magnitudes
of the native models were scaled to the same data as the
WL models (WL_2006). These data highlight that both current
magnitude and specific kinetics contribute to the differences
observed in the mWL models, as the rescaled model variant
did not reproduce the morphology of the mWL model
(Figure 9B).
DISCUSSION
Summary
In this study, mathematical descriptions of the primary ion
currents underlying human atrial electrophysiology were
developed based primarily on congruent human atrial cell
data from a single source, and specifically reproducing the
environment of isolated atrial cardiomyocyte whole-cell-
patch current- and voltage-clamp experiments, including
the frequently observed unphysiologically depolarized
RMP and injected compensating hyperpolarizing current.
Formulations describing the currents Ito, Isus, ICaL, and
IK1 were all fit to voltage-clamp data from the WL
(Figures 1, 3); INa was parameterized using experiments
relating RMP to dV/dtmax (Figure 2). The formulations
were integrated with multiple available existing models of
human atrial electrophysiology which include descriptions
of intracellular calcium handling, to produce a family of
novel and modified models of the human atrial myocyte
(Figure 4). The models were compared to experimental
data describing AP morphology, APD, rate-adaption, and
current magnitudes (Figure 4) as well as pharmacological
and dynamic clamp interventions (Figure 5); model variants
were also compared to each other to elucidate the role of
the primary ion current parameters in human atrial cell
dynamics (Figures 8, 9), and the important differences between
isolated- and intact-cell environments were characterized
(Figure 7).
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FIGURE 7 | Isolated- vs intact-cell properties. (A) Action potentials (a), calcium transient (b), and APD restitution (c) plotted against basic cycle length (BCL), for the
three baseline cell model (i–iii) variants for isolated (blue) and intact (orange). The APD curves were normalized to the intact-cell APD at a cycle length of 2000 ms.
(B) Comparison of isolated (upper) and intact (lower) cell model response to various interventions (gray). Arrows in (iv) lower panel indicate early-after-depolarizations
(EADs).
Comparison to Previous Work
There are many available models describing human atrial
electrophysiology developed by multiple groups. Comprehensive
reviews and comparisons of these models can be found in
Wilhelms et al. (2013), Trayanova (2014), and Heijman et al.
(2016), but these models can be briefly categorized into a few
independent models (Courtemanche et al., 1998; Nygren et al.,
1998; Grandi et al., 2011) and variants of these, introducing,
for example, reformulations due to new data (Maleckar et al.,
2009), mutant ion channel variants (Colman et al., 2017a),
parameterization to patient specific data (Lombardo et al., 2016),
or population variability models (Ellinwood et al., 2017; Lawson
et al., 2018; Ni et al., 2018). Whereas these models are typically
based on data from multiple sources, cell-types, or species,
the ion current formulations developed in the present study
are derived directly from human atrial specific data from a
single laboratory. Importantly, where many previous studies have
adjusted current parameters to reproduce AP properties, no
such modifications were made in the present study, ensuring
that the relative balance and time-courses of the primary
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FIGURE 8 | Comparison of currents under voltage clamp. (A) Current–voltage (IV) curves and (B) Current traces associated with voltage clamp protocols for Ito (i),
Isus (ii), and ICaL (iii) comparing the WL formulations (purple) with those originally presented in the CRN (orange), NG (green), and GB (blue) studies. All current traces
are normalized, and presented on the same temporal scale for comparison.
currents is experimentally justified. Furthermore, the model
presented is the first to explicitly implement the conditions
of isolated-cell experiments and to specifically differentiate
isolated- and intact-cells. Analysis presented in this study
highlights the importance of reproducing these isolated-cell
environmental conditions when considering validation and
comparison of AP response to intervention (sections “Role
of the Hyperpolarizing Current” and “The Importance of the
Isolated-Cell Environment”). Therefore, the models presented
offer advantages for general integrated experimental-numerical
investigation compared to previously presented models which
do not reproduce these conditions, as well as for direct
integration with experiments in the WL for which the model is
tailored. Similar approaches could be applied to develop specific
models for other laboratories and experimental environments;
incidentally, a comparison of such models may provide the best
means to fully assess the impact of inter-laboratory differences
and elucidate the role and variation of ion currents in human
atrial electrophysiology.
The single-source approach implemented theoretically
provides a higher level of confidence than previous models,
due to the absence of arbitrary or results-based parameter
modification and lack of ambiguity in combination of
the formulations of the primary ion currents. However,
this is far from a claim that it is therefore superior, or
that the previous models are “less-valid”; rather, at the
very least, the formulations presented in this study, and
the models which implement them, exhibit differences
to those previous models (section “Comparison Between
Models”) and therefore represent complementary tools
which may assist in multi-model studies to provide a further,
independent perspective and thus achieve model-independent
conclusions.
The Importance of the Isolated-Cell
Environment
Isolated human atrial cardiomyocytes frequently feature
unphysiologically depolarized RMP (Escande et al., 1987;
Bénardeau et al., 1996; Dobrev et al., 2001; Workman et al.,
2006) and apparent reversal of IK1 at ∼40 mV. This issue
has been addressed in a variety of ways; e.g., by current-
clamping with a small, constant, hyperpolarizing current
(Le Grand et al., 1994; Bénardeau et al., 1996; Workman
et al., 2001). However, the previous models do not explicitly
account for such RMP depolarization or hyperpolarizing
current application (although studies in ventricular cells
have investigated the effect of applied constant currents on
APD at different rates, e.g., Grandi et al., 2010). Results
presented in this study (section “Role of the Hyperpolarizing
Current”), and based on the available, well-established human
atrial cell models (i.e., independent of novel ion current
formulations), demonstrated that these features can lead to
significantly different behavior compared to “intact”-cells (i.e.,
the models as natively presented, with IK1 reversal ∼ EK and
a well maintained RMP of more negative than −70 mV): all
isolated-cell model variants exhibited a shorter APD90 and a
smaller CaT than the intact equivalents. In the hAM_CRN
model, the different environments resulted in the difference
between “spike-and-dome” versus “low-dome/triangulated” AP
morphologies, which may have a significant impact on model
dynamics.
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FIGURE 9 | Comparison of excitation and current properties between the different models. (A) Comparison of the AP and primary current time-courses associated
with the baseline (orange) and modified (blue) cell models, with the full WL model implemented in the baseline model’s calcium handling system shown where
relevant (purple dotted). For each baseline model (i–iii; CRN, GB, NG), data are shown for both isolated and intact-cell variants (left and right of each panel). The
scale bar indicates 50 ms in each panel. (B) Comparison of native and modified cell models (orange and blue) with the native model rescaled by the Workman
laboratory data (green) for the same cell models and conditions as panel A.
Furthermore, the models responded differently to the
application of interventions, in some cases in significant ways
such as APD shortening vs lengthening, or the emergence
of EADs. Some of these differences may simply be a result
of AP morphology and its influence on the time-course of
the underlying ion currents, but it is also highly likely that
the more positive reversal potential and constant, injected
hyperpolarizing current, as well as the absence of IKr/IKs, more
directly underlies these differences to at least some extent (IKr
and IKs, for example, being responsible for accelerated terminal
repolarization associated with AP plateau elevation in intact-cell
models).
These results therefore highlight the considerations which
must be taken when validating human atrial cell models
against experimental data attained under these isolated-cell
conditions, for translation of phenomena observed under
perturbed conditions to the tissue scale, and for experimentally
assessing model predictions attained without accounting for
these conditions.
Potential Contributions of IKr and IKs to
Human Atrial Repolarization
Due to IKs and IKr being very small or absent (Firek and
Giles, 1995; Amos et al., 1996; Schreieck et al., 2000; Caballero
et al., 2010) in isolated human atrial cells, these currents were
not included in the isolated-cell model. Repolarization kinetics
and duration properties matched well with experimental traces,
indicating that these currents are not required for repolarization
under these conditions. Extrapolation to the intact-cell model, in
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which Ihyp was removed, indicated that IKr/IKs may be required
in the intact human atria to maintain repolarization, as cell
models exhibited prolonged (>700 ms) or non-repolarizing APs
without inclusion of these currents. However, inclusion of these
currents to only a relatively small magnitude was sufficient to
maintain AP repolarization.
Limitations
Whereas the primary ion currents controlling the AP model were
fit to detailed data from a single laboratory, the intracellular Ca2+
handling system was not parameterized to the same extent to
human atrial data, and only limited CaT data were available for
validation from the WL. For this reason, the current formulations
were integrated with multiple contemporary human atrial
calcium handling systems, rather than performing development
and parameterization of a novel calcium handling system.
However, the development of a more rigorously derived human
atrial specific calcium handling system (for example, an extension
of the spatial cell model presented in Voigt et al., 2014) would be a
natural improvement to a full human atrial single-source model.
Furthermore, integration with multiple, independent systems
provided challenges for modeling the L-type calcium current
homogeneously across the different models, due to the tight and
sensitive coupling between this current and the calcium handling
system. This led to a degree of uncertainty and subjectivity in
the selection of parameters from non-unique solutions, which
contrasts with the single-source and objective philosophy of the
approach.
In general, the models and variants overestimated the impact
of high concentrations of nifedipine on human atrial AP
shortening. Whereas this feature is common to many models of
the human atria, and in particular in the isolated-cell variants
as presented in this study, its emergence in a model containing
accurately reproduced dynamics for the main ion currents
characterized in experiments suggests a potential important
role of inward currents active at potentials more negative than
−30 mV not captured in the model, possibly because INCX
is too small, or the presence of larger background Ca2+ and
Na2+ currents. This type of insight, however, supports a primary
purpose of the model: for example, the potential role of incorrect
relative current magnitude balance in the formulations of the
primary currents underlying this discrepancy can be largely
eliminated.
Variability was not investigated in the present study, although
the single-source approach may offer the perfect tool to interpret
data attained from the implementation of a full population
variability approach and/or quantification through sensitivity
analysis (Chang et al., 2015; Devenyi et al., 2017; Ellinwood et al.,
2017; Sánchez et al., 2017; Lawson et al., 2018; Ni et al., 2018).
Due to the single-source, minimalistic philosophy of the
approach, there are many factors which play a role in human
atrial electrophysiology which have not been included, due to
a lack of well characterized and human atrial specific data.
For example, the models do not contain detailed descriptions
of phosphorylation due to PKA, or the impact of CaMKII
(and serine and threonine; Heijman et al., 2014, 2017; Mesubi
and Anderson, 2016), or additional currents such as small
conductance potassium channels (Skibsbye et al., 2014), which
may have an important influence on human atrial cell dynamics
in control and perturbed conditions. Exclusion of these
components is not a claim that they are unimportant, but rather
follows from the motivation not to introduce sophistication and
complexity by including components which have not been well
characterized in the human atria (and specifically the WL) and
thus contain potential sources of error, ad hoc parameters, or
inaccurately scaled contributions. We hope that in future further,
well-characterized components will be added to the model as
part of the long-term ambition of the biophysically detailed and
biomedically accurate virtual human heart.
CONCLUSION
We have developed a family of biophysically detailed models
of human atrial electrophysiology based primarily on data from
a single laboratory and reproducing the conditions of isolated-
cell experiments. The models reproduce human atrial excitation
properties and the impact of various interventions, and the
importance of the isolated-cell environment was highlighted. We
therefore present a tool which can be used directly in conjunction
with experiments to dissect the ionic mechanisms of atrial
arrhythmias, and complementary to the available contemporary
cell models for general mechanistic investigation.
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